Marc Grasso insider trades
Open-market stock purchases and sales by Marc Grasso, Chief Financial Officer at Kyverna Therapeutics, Inc, from SEC Form 4 filings since Aug 21, 2018.
Open-market stock purchases and sales by Marc Grasso, Chief Financial Officer at Kyverna Therapeutics, Inc, from SEC Form 4 filings since Aug 21, 2018.